During breast cancer bone metastasis progression, the TGF-β induced bone metastatic genes expression were found depend on SMAD3 but not SMAD2, and knockdown of SMAD3 in MDA-MB-231 cells inhibited bone metastasis, while SMAD3 knockdown led to a more aggressive phenotype [8]. Here, SMAD3 is linked to breast carcinoma.